Abstract：Objective To study the mutation characteristics of the phenylalanine hydroxylase (PAH) gene in children with phenylketonuria (PKU) from the Qinghai area of China, in order to provide basic information for genetic counseling and prenatal diagnosis. Methods Mutations of the PAH gene were detected in the promoter and exons 1-13 and their flanking intronic sequences of PAH gene by PCR and DNA sequencing in 49 children with PKU and their parents from the Qinghai area of China. Results A total of 30 different mutations were detected in 80 out of 98 mutant alleles (82%), including 19 missense (63%), 5 nonsense (17%), 3 splice-site (10%) and 3 deletions (10%). Most mutations were detected in exons 3, 6, 7, 11 and intron 4 of PAH gene. The most frequent mutations were p.R243Q (19%), IVS4-1G>A (9%), p.Y356X (7%) and p.EX6-96A>G(5%). Two novel mutations p.N93fsX5 (c.279-282delCATC) and p.G171E (c.512G>A) were found. p.H64fsX9(c.190delC) was documented for the second time in Chinese PAH gene. The mutation spectrum of the gene PAH in the Qinghai population was similar to that in other populations in North China while significantly different from that in the populations from some provinces in southern China, Japan and Europe. Conclusions The mutations of PAH gene in the Qinghai area of China demonstrate a unique diversity, complexity and specificity.
HE Jiang,WANG Hui-Zhen,XU Fa-Liang et al. Mutation analysis of the PAH gene in children with phenylketonuria from the Qinghai area of China[J]. CJCP, 2015, 17(11): 1221-1227.
Guldberg P, Romano V, Cerattp NP, et al. Mutational spectrum of phenylalanine hydroxylase defiency in Sicily: implications for diagnosis of hyper pheenylalaninemaia in Southern Europe[J]. Hum Mol Genet, 1993, 2(10): 1703-1707.
Chien YH, Chiang SC, Huang A, et al. Mutation apectrum in Taiwanese patients with phenylalanine hydroxylase deficiency and a founder effect for the R241C mutation[J]. Hum Mutat, 2004, 23(2): 206.
[12]
Shen DY, Wu W, Zhao ZY. Mutations in patients with hyperphenylalaninemia in zhejiang, China[J]. Genes Genom, 2009, 31(1): 85-88.
Okano Y, Asada M, Kang Y, et al. Molecular characterization of phenylketonuria in Japanese patients[J]. Hum Genet, 1998, 103(5): 613-618.
[15]
Johamnes Z. Phenylketonuria mutations in Europe[J]. Hum Mutat, 2003, 21(4): 345-356.
[16]
Yu WZ, Qiu DH, Song F, et al. Mutation characteristics of the PAH gene in four Nationality groups in Xinjiang of China[J]. J Genet, 2008, 87(3): 293-297.
[17]
Zhu TW, Qin SY, Ye J, et al. Mutational spectrum of phenylketonuria in the Chinese Han population: a novel insight into the geographic distribution of the common mutations[J]. Pediatr Res, 2010, 67(3): 280-285.
[18]
Couce ML, Boveda MD, Femandez-Marmiesse A, et al. Molecular epidemiology and BH4-responsiveness in patients with phenylalanine hydroxylase deficiency from Galicia region of Spain[J]. Gene, 2013, 521(1): 100-104.
[19]
Hamzehloei T, Hosseini SA, Vakili R, et al. Mutation spectrum of the PAH gene in the PKU patients from Khorasan Razavi province of Iran[J]. Gene, 2012, 506(1): 230-232.
[20]
Daniele A, Scala I, Cardillo G, et al. Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy[J]. FEBS J, 2009, 276(7): 2048-2059.
